Common Contracts
7 similar Common Stock Purchase Agreement contracts by Geron Corp
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • August 20th, 2010 • Geron Corp • Pharmaceutical preparations • California
THIS COMMON STOCK PURCHASE AGREEMENT (“Agreement”) is made and entered into as of August 16, 2010 (the “Effective Date”), by and between GERON CORPORATION, a Delaware corporation having its principal place of business at 230 Constitution Drive, Menlo Park, California 94025 (“Geron”), and Samchully Pharm. Co., Ltd., having a principal place of business at 7F MSA Bldg., 891-43 Daechi-dong Gangnam-gu Seoul, Korea 135-840 (“Manufacturer”).
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • August 20th, 2010 • Geron Corp • Pharmaceutical preparations • California
THIS COMMON STOCK PURCHASE AGREEMENT (“Agreement”) is made and entered into as of August 16, 2010 (the “Effective Date”), by and between GERON CORPORATION, a Delaware corporation having its principal place of business at 230 Constitution Drive, Menlo Park, California 94025 (“Geron”), and HONGENE BIOTECHNOLOGY LIMITED, having its principal place of business at Room 203, Building 8, No. 500 CaoBao Road, Shanghai, China, 200233; Tel: 0086-21-64757213, 0086-21-54971054 Fax: 0086-21-6470061 (“Manufacturer”).
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • April 9th, 2010 • Geron Corp • Pharmaceutical preparations • Delaware
THIS COMMON STOCK PURCHASE AGREEMENT (“Agreement”) is made and entered into as of April 1, 2010 (the “Effective Date”), by and between GERON CORPORATION, a Delaware corporation having its principal place of business at 230 Constitution Drive, Menlo Park, California 94025 (“Geron”), and Girindus America Inc., a Delaware corporation having its principal place of business at 8560 Reading Road, Cincinnati, Ohio, 45215 (“Manufacturer”).
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • January 27th, 2010 • Geron Corp • Pharmaceutical preparations • California
THIS COMMON STOCK PURCHASE AGREEMENT (“Agreement”) is made and entered into as of January 22, 2010 (the “Effective Date”), by and between GERON CORPORATION, a Delaware corporation having its principal place of business at 230 Constitution Drive, Menlo Park, California 94025 (“Geron”), and Samchully Pharm. Co., Ltd., having a principal place of business at 947-7, Daechi-dong, Gangnam-gu, Seoul, Korea (“Manufacturer”).
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • November 16th, 2009 • Geron Corp • Pharmaceutical preparations • California
THIS COMMON STOCK PURCHASE AGREEMENT (“Agreement”) is made and entered into as of November 6, 2009 (the “Effective Date”), by and between GERON CORPORATION, a Delaware corporation having its principal place of business at 230 Constitution Drive, Menlo Park, California 94025 (“Geron”), and Samchully Pharm. Co., Ltd., having a principal place of business at 947-7, Daechi-dong, Gangnam-gu, Seoul, Korea (“Manufacturer”).
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • November 16th, 2009 • Geron Corp • Pharmaceutical preparations • California
THIS COMMON STOCK PURCHASE AGREEMENT (“Agreement”) is made and entered into as of November 6, 2009 (the “Effective Date”), by and between GERON CORPORATION, a Delaware corporation having its principal place of business at 230 Constitution Drive, Menlo Park, California 94025 (“Geron”), and HONGENE BIOTECHNOLOGY LIMITED, having its principal place of business at Room 203, Building 8, No. 500 CaoBao Road, Shanghai, China, 200233; Tel: 0086-21-64757213, 0086-21-54971054 Fax: 0086-21-6470061 (“Manufacturer”).
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • January 29th, 2009 • Geron Corp • Pharmaceutical preparations • California
THIS COMMON STOCK PURCHASE AGREEMENT (“Agreement”) is made and entered into as of January 27, 2009 (the “Effective Date”), by and between GERON CORPORATION, a Delaware corporation having its principal place of business at 230 Constitution Drive, Menlo Park, California 94025 (“Geron”), and Samchully Pharm. Co., Ltd., having a principal place of business at 947-7, Daechi-dong, Gangnam-gu, Seoul, Korea (“Manufacturer”).
